Unknown

Dataset Information

0

Anti‐sclerostin antibodies for the treatment of osteoporosis

ABSTRACT:

SUBMITTER: Pundole X 

PROVIDER: S-EPMC6478239 | biostudies-literature | 2017 Apr

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown Osteoporosis Treatment with Anti-Sclerostin Antibodies-Mechanisms of Action and Clinical Application.
| S-EPMC7920044 | biostudies-literature
Unknown Sclerostin antibodies in osteoporosis: latest evidence and therapeutic potential.
| S-EPMC5613857 | biostudies-literature
Unknown Sclerostin inhibition: a novel therapeutic approach in the treatment of osteoporosis.
| S-EPMC4459616 | biostudies-literature
Unknown Sclerostin Antibody Therapy for the Treatment of Osteoporosis: Clinical Prospects and Challenges.
| S-EPMC4899597 | biostudies-literature
Unknown Sclerostin-antibody treatment of glucocorticoid-induced osteoporosis maintained bone mass and strength.
| S-EPMC4958115 | biostudies-literature
Unknown Protection From Glucocorticoid-Induced Osteoporosis by Anti-Catabolic Signaling in the Absence of Sost/Sclerostin.
| S-EPMC8499032 | biostudies-literature
Unknown In silico design of novel precision vaccine targeting sclerostin epitopes for osteoporosis prevention and treatment.
| S-EPMC12702773 | biostudies-literature
Unknown Anti-Sclerostin antibody inhibits internalization of Sclerostin and Sclerostin-mediated antagonism of Wnt/LRP6 signaling.
| S-EPMC3639248 | biostudies-literature
Unknown Fracture rate associated with quality metric-based anti-osteoporosis treatment in glucocorticoid-induced osteoporosis.
| S-EPMC4401629 | biostudies-literature
Unknown Anti CD38 monoclonal antibodies for multiple myeloma treatment.
| S-EPMC9225612 | biostudies-literature